Benzinga

FEBRUARY 2, 2023

RESEARCH TRIANGLE PARK, N.C., 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. The asset purchase accelerates Science 37's existing development plans for workflow features such as advanced scheduling and investigational product tracking, and data exchange with Electronic Data Capture and Electronic Medical Record systems.

Technology 40

Technology 40

Benzinga

OCTOBER 1, 2022

Waltham, MA, September 30, 2022 – Wolters Kluwer Health announced today that it has signed and completed an agreement to acquire IJS Publishing Group (IJS PG ) , a UK-based provider of peer-reviewed medical journals supporting scientists and authors.

40

40

Benzinga

DECEMBER 4, 2023

The Pentavere acquisition adds revenue, new pharmaceutical and life sciences customers, access to hospitals as well as growing HEALWELL's dedicated team of AI engineers. TORONTO, Dec. TORONTO, Dec. HEALWELL's majority acquisition of Pentavere further solidifies its standing as a world-class AI technology provider.

Technology 45

Technology 45

Brian DeChesare

NOVEMBER 1, 2023

The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. These firms lie in the territory of life science venture capital firms that invest in high-risk, early-stage companies.

Equity 59

Equity Private Equity Firm Start-ups Banking 59

Benzinga

MARCH 20, 2023

Together, the companies would provide patients with true end-to-end neurological solutions using Brain Scientific's diagnostic and motion technologies and IMAC's regenerative rehabilitation medical services. IMAC is comprised of two business segments: outpatient medical centers and a clinical research division.

Technology 40

Technology 40

Benzinga

DECEMBER 18, 2023

The Transaction reflects a transformation of the business to one focused on the research, development and commercialization of proprietary science and technologies for therapeutics, diagnostics and services for the treatment of cancer. ownership stake of Onconetix. Campbell. "As

Compliance 40

Compliance Technology Marketability 40

Benzinga

SEPTEMBER 28, 2022

Besides, the introduction to virtual biobanking is set to revolutionize the system by enabling researchers to conduct their studies smoothly, as well as by lowering the time constraints. Nowadays, cord blood is considered to be an important source of stem cells that is often processed and conserved for medical research.

Marketability 40

Marketability Technology 40

Benzinga

APRIL 12, 2022

Besides, the introduction to virtual biobanking is set to revolutionize the system by enabling researchers to conduct their studies smoothly, as well as by lowering the time constraints. Nowadays, cord blood is considered to be an important source of stem cells that is often processed and conserved for medical research.

Marketability 52

Marketability Technology 52

Benzinga

JANUARY 4, 2023

Vyasa provides scalable deep-learning software which allows life sciences organizations to perform predictions and answer complex questions across structured and unstructured bio-medical information. (NASDAQ: CERT ), today announced it has acquired Vyasa Analytics, LLC. Feehery, Chief Executive Officer of Certara. "By

40

40

Benzinga

MARCH 18, 2023

Luton, Bedfordshire, United Kingdom, March 18, 2023 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Healthcare AI Market. Full story available on Benzinga.com

Marketability 40

Marketability Technology 40

Benzinga

JULY 13, 2022

launched FLIR A8580 series of thermal cameras designed for military, science, industrial, and product research and development (R&D) applications. Request a Sample Copy of the Research Report: [link]. KEY INDUSTRY DEVELOPMENTS: February 2020: - FLIR Systems, Inc.

Marketability 40

Marketability 40

Benzinga

MARCH 4, 2024

ARTMS, based in Burnaby, British Columbia (BC), Canada, is a privately held, venture-backed company, which specialises in the physics, chemistry and materials science of cyclotron-produced radionuclides. Development of ‘next generation' cyclotron targets to support the safe and high-yield production of therapeutic radionuclides.

Alpha 45

Alpha Technology 45

Benzinga

AUGUST 10, 2022

Todos Medical says Provista Diagnostics lab finishes validation of Wound and Respiratory Pathogen panels; plans to add monkeypox testing click here. Lobe Sciences enters into exclusive agreement with contract research organization iNGEN? New York, NY, Aug. 10, 2022 (GLOBE NEWSWIRE) -- New York, NY, Aug.

Marketability 40

Marketability 40

Benzinga

NOVEMBER 15, 2023

HEALWELL enters into agreement to acquire a majority stake of Pentavere, a healthcare artificial intelligence (AI) company whose DARWEN™ AI technology has been validated by some of the largest pharmaceutical companies in the world and whose research and validation has been published by some of the most prestigious publications globally.

Technology 40

Technology 40

Benzinga

JUNE 16, 2022

Salt Lake City, Utah, June 16, 2022 (GLOBE NEWSWIRE) -- CenExel announces the acquisition of Apex Innovative Sciences, parent company of Collaborative Neuroscience Research (CNS) and Hassman Research Institute (HRI), which will be renamed as "CenExel CNS" and "CenExel HRI", respectively, going forward.

40

40

Benzinga

AUGUST 23, 2022

Precision medicine market brings together multiple branches of medical science, including epidemiology, genomics, proteomics, and bioinformatics. The medical world is continually evolving as new and more precise treatments become available. This money is being put to good use by researchers across the.

Marketability 40

Marketability 40

Benzinga

JULY 29, 2022

Pune, India, July 29, 2022 (GLOBE NEWSWIRE) -- The Contract Research Organization (CRO) Services market size was USD 62.75 Additionally, increased investment opportunities by pharmaceutical, biopharmaceutical, and medical device companies will increase the footprint of the market. Request a Sample Copy of the Research Report: [link].

Marketability 40

Marketability Technology 40

Benzinga

JULY 11, 2022

Factors such as rising R&D budgets and rising outsourcing activities from pharmaceuticals along with rising collaborative efforts will boost the growth of the Contract Research Organization Services market united states during the forecast period. Request a Sample Copy of the Research Report: [link]. Industry Development.

Marketability 40

Marketability Technology 40

Benzinga

FEBRUARY 22, 2023

Get a Free Sample Research Report: [link] CBD gummies are a popular way to consume CBD because they are discreet, convenient, and easy to dose. CV Sciences, Inc. They are typically made using CBD isolate or full-spectrum CBD extract, which contains other beneficial compounds found in the cannabis plant, such as terpenes and flavonoids.

Marketability 40

Marketability 40

Cooley M&A

JANUARY 23, 2024

In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. Why did life sciences outperform the market? More than half of all life sciences M&A activity in 2023 was for private and small-cap biopharma sellers.

Marketability 52

Marketability Equity Private Equity Firm Finance 52

Benzinga

MAY 3, 2022

Canaccord Genuity repeats 'Speculative Buy' rating on Think Research stock following recent Q4 results click here. Wellbeing Digital Sciences names Dr Michael Ho as medical director of its MindScape ketamine clinic click here. Western Magnesium applauds US national effort to secure critical minerals click here.

Technology 40

Technology 40

Benzinga

SEPTEMBER 23, 2022

Alopecia areata is a medical condition that results in hair loss in patches for both males and females. Major Industry Developments of the Market include: March 2020 – Clinical study of the one-time injection called RCH-01 for androgenic alopecia was announced to be successful in Japan by RepliCel Life Sciences Inc. Forecast Period.

Marketability 40

Marketability 40

Benzinga

JULY 15, 2022

Fortune Business Insights™ has deep-dived these inputs in its latest research report, titled, " Healthcare Personal Protective Equipment (PPE) Market, 2022-2029 ". According to an analysis, the rising footprint of medical artificial intelligence could encourage leading companies to boost their portfolios. billion by 2029 at 4.2%

Alpha 40

Alpha Marketability 40

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

Marketability 40

Marketability Finance Equity Debt Financing 40

Benzinga

APRIL 4, 2022

Additionally, increased investment opportunities by pharmaceutical, biopharmaceutical, and medical device companies will increase the footprint of the market. Request a Sample Copy of the Research Report: [link]. Industry Development. July 2021: Pharmaceutical Product Development, LLC.

Marketability 40

Marketability Technology 40

Benzinga

JANUARY 16, 2024

Mediforum is a leading biotechnology company in Korea that focuses on researching and developing ethical drugs and diagnostic reagents, and strategic application products primarily derived from natural material i.e., Korean and oriental traditional medicine to ensure safety and efficacy.

Enterprise Value 40

Enterprise Value Finance Equity Technology 40

Cooley M&A

JANUARY 20, 2022

General trends in life sciences M&A. Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. Increased focus on digitization, with life sciences companies placing a premium on innovative and tech?driven driven assets.

Marketability 40

Marketability Start-ups Equity Technology 40

Benzinga

AUGUST 31, 2022

Ocean Biomedical's innovative business model bridges the ‘bench-to-bedside' gap by accelerating the commercialization of innovative assets from research universities and medical centers. She has held strategy/portfolio management leadership roles at Gilead Sciences, Merck and Co, and BioMarin Pharmaceutical.

Enterprise Value 40

Enterprise Value Technology Marketability 40

Cooley M&A

JANUARY 22, 2020

2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2

Marketability 40

Marketability Technology 40

Viking Mergers

OCTOBER 1, 2022

5 Life and Biomedical Science. Life science and biomedical research are a top priority in Charleston. The Charleston area produces top talent in the biomedical and life science field thanks to state-of-the-art education at nearby universities and technical schools.

Technology 26

Technology Marketability 26

Benzinga

OCTOBER 13, 2022

Importantly, ELVN-001 was designed to be a more attractive option for patients with comorbidities, on concomitant medications or desiring more freedom. Companies to host conference call today at 5:00 p.m. Boulder, CO and Boston, MA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. Full story available on Benzinga.com.

Finance 40

Finance Marketability 40

Benzinga

OCTOBER 26, 2022

Sumitomo Pharma), and Myovant Sciences (Myovant) announced that they have entered into a definitive agreement pursuant to which Sumitovant will acquire all outstanding shares of Myovant not already owned by Sumitovant for $27.00 Research and development (R&D) expenses for the three months ended September 30, 2022, and 2021 were $26.9

Start-ups 40

Start-ups Marketability Technology 40

Benzinga

MAY 18, 2022

Additionally, Le Pragma's cutting-edge formulations and dedication to a precise science sets Le Pragma products apart from other companies, delivering optimal wellness throughout its entire retail line. This includes clinical trials, proper usage recommendations, and scientific background on the products being released.

Marketability 40

Marketability 40

The Guardian M&A

MARCH 19, 2024

Britain’s biggest drugmaker’s latest acquisition will help it to develop new radiotherapy treatments Business live – latest updates Britain’s biggest drugmaker, AstraZeneca, is to buy a Canadian cancer specialist focused on next-generation treatments for $2.4bn (£1.9bn), the latest in a string of acquisitions made to strengthen its portfolio of new (..)

94

94

Cooley M&A

JUNE 10, 2020

On May 27th, Andy Pasternak, Executive Vice President, Chief Strategy Officer at Horizon Therapeutics and Eric Tokat, a partner in the healthcare practice at Centerview Partners joined Cooley M&A co-chair, Barbara Borden for a discussion of the life sciences M&A market, with a focus on business development.

Marketability 40

Marketability 40

The Guardian M&A

DECEMBER 12, 2023

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid-19 pandemic.

82

82

Benzinga

NOVEMBER 4, 2022

On October 6, the Company hosted a key opinion leader (KOL) webinar on the unmet medical needs and evolving treatment landscape of desmoid tumors: The webinar featured presentations by Professors Bernd Kasper, MD, Ph.D., R&D Expenses : Research and development expenses were $7.2 million for the corresponding quarter in 2021.

Marketability 40

Marketability Technology Finance 40